EUVIMEDEUVIMED entdecken
Crossref

The dual role of angiotensin ii: From cardiovascular repair to tumor progression

Yimao Wu, Xiaoyan Chen, Yalun Liang, Meng-Yao Li, Shuai Ren

Journal of the Renin-Angiotensin-Aldosterone System · 2026-08 · 27

DOI: 10.1177/14703203261475852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Renin-Angiotensin-Aldosterone System, online erschienen am 10.08.2026. Verfasst von Yimao Wu und 4 weiteren Autor:innen. Die Arbeit nennt 234 Literaturangaben. Gefördert von: Jiangsu Provincial Key Research and Development Program, Developing Program for High-level Academic Talent in Jiangsu Hospital of Chinese Medicine, The Open Project of Jiangsu Provincial Science and Technology Resources (Clinical Resources) Coordination Service Platform.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Angiotensin II (Ang II), the principal effector of the renin–angiotensin system, exhibits context-dependent dual roles in cardiovascular and oncological pathophysiology. This review systematically examines the molecular mechanisms underlying its contrasting functions in tissue repair and tumor progression while exploring the clinical translational implications of this functional plasticity.

Methods

Evidence on Ang II generation pathways, receptor subtype signaling, and downstream molecular networks was synthesized. The analysis focused on how receptor balance, microenvironmental cues, and signaling pathway crosstalk determine biological outcomes.

Results

In cardiovascular injury, transient low-concentration Ang II preferentially activates the protective AT2R and ACE2/Ang-(1–7)/Mas axes, promoting angiogenesis and anti-inflammatory repair. Conversely, in tumors, chronic hypoxia sustains AT1R activation, triggering Mitogen-activated protein kinase / Extracellular signal-regulated kinase (MAPK/ERK), phosphatidylinositol 3-kinase/protein kinase B(PI3 K/AKT), and Hypoxia-inducible factor / Vascular endothelial growth factor (HIF-VEGF) signaling that drive proliferation, EMT, immunosuppression, and therapy resistance. This functional shift depends on receptor subtype ratio, tissue microenvironment characteristics, and signaling node crosstalk.

Conclusion

Ang II acts as a bifunctional modulator rather than a detrimental factor, with its net effects determined by dynamic regulatory networks. Targeting this duality through receptor-specific strategies, combination immunotherapies, and stage-adaptive interventions may support precision therapeutic approaches for cardiovascular diseases, oncology, and cardio-oncology comorbidities.

Förderung

  • Jiangsu Provincial Key Research and Development Program
  • Developing Program for High-level Academic Talent in Jiangsu Hospital of Chinese Medicine
  • The Open Project of Jiangsu Provincial Science and Technology Resources (Clinical Resources) Coordination Service Platform
  • Young Elite Scientists Sponsorship Program by China Association of Chinese Medicine
  • Foundation of Excellent Young Doctor of Jiangsu Province Hospital of Chinese Medicine

Zitieren

APA

Wu, Y., Chen, X., Liang, Y., Li, M., & Ren, S. (2026). The dual role of angiotensin ii: From cardiovascular repair to tumor progression. Journal of the Renin-Angiotensin-Aldosterone System, 27. https://doi.org/10.1177/14703203261475852

Vancouver

Wu Y, Chen X, Liang Y, Li M, Ren S. The dual role of angiotensin ii: From cardiovascular repair to tumor progression. Journal of the Renin-Angiotensin-Aldosterone System. 2026;27. doi:10.1177/14703203261475852

BibTeX
@article{Wu2026,
  author = {Wu, Yimao and Chen, Xiaoyan and Liang, Yalun and Li, Meng-Yao and Ren, Shuai},
  title = {The dual role of angiotensin ii: From cardiovascular repair to tumor progression},
  journal = {Journal of the Renin-Angiotensin-Aldosterone System},
  year = {2026},
  volume = {27},
  doi = {10.1177/14703203261475852}
}
Kostenlos starten →